DOCSLIB.ORG

Understadning the Regulation of Endogenous Trpv2 by Growth Factors in Neuronal Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

UNDERSTADNING THE REGULATION OF ENDOGENOUS TRPV2 BY GROWTH FACTORS IN NEURONAL CELLS by MATTHEW RYAN COHEN Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Advisor: Vera Moiseenkova-Bell Department of Physiology and Biophysics CASE WESTERN RESERVE UNIVERSITY January 2016 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of MATTHEW RYAN COHEN candidate for the degree of Physiology and Biophysics*. Witold Surewicz (Committee Chair) Sudha Chakrapani Vera Moiseenkova-Bell Xin Qi William Schilling David Van Wagoner November 5, 2015 *We also certify that written approval has been obtained for any proprietary material contained therein. Table of Contents List of tables VI List of figures VII Acknowledgements X Abstract XI CHAPTER 1: INTRODUCTION 1 1.1 The Transient Receptor Potential family of ion channels 2 1.2 TRPV channels as thermosensors 2 1.3 Domain structure of thermoTRPV channels 3 1.4 Involvement of TRPV2 in sensory transduction 4 1.5 Pharmacological Activation and Inhibition of TRPV2 6 1.6 Subcellular trafficking of TRPV2 10 1.7 Involvement of TRPV2 in nervous system function and axon extension 12 1.8 Neurotrophins and their receptors 13 1.9 Retrograde transport of neurotrophin signals 17 1.10 Ca2+ as a second messenger in neurotrophin signaling 20 1.11 TRP channels in neurite outgrowth and neurotrophin signaling 21 1.12 Purpose of this study 23 1.13 Figures 25 1.14 Table 33 i CHAPTER 2: EFFECT OF GROWTH FACTORS, INCLUDING IGF-1, ON TRPV2 TRANSLOCATION TO THE PLASMA MEMBRANE 34 2.1 Introduction 35 2.2 Materials and Methods 38 2.2.1 Ethics Statement 38 2.2.2 Plasmids 38 2.2.3 Protein expression and purificiation 38 2.2.4 TRPV2 antibody generation 39 2.2.5 Commercially available antibodies 39 2.2.6 Cell culture and transfection 39 2.2.7 Mouse tissue lysate generation and immunoprecipitation 40 2.2.8 Western blot analysis 41 2.2.9 Immunocytochemistry 41 2.2.10 Biotinylation of cell surface proteins 42 2.3 Results 43 2.3.1 Translocation of overexpressed TRPV2 in response to growth factors 43 2.3.2 Detection of recombinant TRPV2 and determination of TRPV2 binding region 45 2.3.3 Recognition of endogenously expressed TRPV2 46 2.3.4 Immunoprecipitation of TRPV2 from mouse brain and heart 47 2.3.5 Detection of TRPV2 by immunocytochemistry 48 2.3.6 Effect of IGF-1 on cell surface expression of TRPV2 49 2.4 Discussion 50 ii 2.5 Figures 55 CHAPTER 3: MAPK/ERK REUGLATES TRPV2 DOWNSTREAM OF NGF TO ENHANCE NEURITE OUTGROWTH 65 3.1. Introduction 66 3.2. Materials and Methods 68 3.2.1 Chemicals and antibodies 68 3.2.2 Cell culture and transfection 69 3.2.3 Dissociation and culture of primary E18 DRG neurons 69 3.2.4 Plasmids 70 3.2.5 Site-directed mutagenesis 70 2+ 3.2.6 Cytosolic Ca measurements 71 3.2.7 Western blot analysis 72 3.2.8 Removal of N-linked glycans 72 3.2.9 RNA extraction and cDNA synthesis 72 3.2.10 Semiquantitative RT-PCR of TRPV2 and GAPDH 73 3.2.11 Immunofluorescence 74 3.2.12 Cell surface biotinylation 74 3.2.13 Morphology analysis of PC12 cells 74 3.2.14 In vitro kinase assay 75 3.2.15 Isolation of TRPV2 from HEK293T cells and mass spectrometry analysis 76 3.2.16 Statistical analyses 77 3.3. Results 77 iii 3.3.1 TRPV2 is expressed in developing neurons and regulated by NGF 77 3.3.2 TRPV2 enhances NGF-induced neurite outgrowth 80 3.3.3 NGF-induced increase in TRPV2 protein is mediated by MAPK signaling 83 3.3.4 NGF does not induce TRPV2 translocation to the plasma membrane in PC12 cells 85 3.3.5 ERK phosphorylates TRPV2 to enhance neurite outgrowth 86 3.4. Discussion 89 3.5. Figures 95 CHAPTER 4: DISCUSSION AND FUTURE DIRECTIONS 112 4.1. Summary 113 4.2. Generation of monoclonal TRPV2 antibodies suitable for detection of endogenously expressed TRPV2 113 4.3. Regulation of TRPV2 by NGF signaling in developing neurons 117 4.4. Remaining questions 122 4.4.1 Is TRPV2 regulated downstream of NGF/MAPK in vivo? 122 2+ 4.4.2 Does TRPV2 activity directly affect endosomal Ca levels? 122 4.4.3 How is TRPV2 targeted to endosomes in developing neurons? 124 4.5. Potential mechanisms by which TRPV2 promotes neurite extension 125 2+ 4.5.1 TRPV2-mediated Ca signals might affect cytoskeletal structure in growing neurites 125 2+ 4.5.2 Potential influence of TRPV2-mediated Ca signals on Rab7 activity and signaling endosome function 127 iv 4.5.3 Potential role of TRPV2 in neuronal regeneration 130 4.5. Concluding remarks 132 4.6. Figures 133 APPENDIX 137 REFERENCES 138 v List of Tables Table 1.1. Modulators of TRPV2 activity 33 vi List of Figures Figure 1.1. The mammalian Transient Receptor Potential (TRP) Family 25 Figure 1.2. Function of TRPV subfamily members 26 Figure 1.3. Domain structure of thermoTRPV channels 27 Figure 1.4. Neurotrophins and their receptors 28 Figure 1.5. Effect of NGF on PC12 cell morphology 29 Figure 1.6. Schematic representing the major signaling pathways activated by NGF 30 Figure 1.7. Cartoon depicting receptor-mediated endocytosis 31 Figure 1.8. Cartoon depicting long-distance retrograde transport of NGF/TrkA-containing signaling endosomes 32 Figure 2.1. Treatment of F11 cells with IGF-1 does not induce translocation of overexpressed TRPV2 to the plasma membrane 55 Figure 2.2. IGF-1 treatment does not induce translocation of overexpressed TRPV2 to the plasma membrane in HeLa cells 56 Figure 2.3. Immuno-detection of recombinant TRPV2 and mapping of the TRPV2 binding region 57 Figure 2.4. TRPV2 monoclonal antibody recognizes endogenous TRPV2 by western blot 58 Figure 2.5. Immunoprecipitation of endogenous TRPV2 59 Figure 2.6. Immunostaining with TRPV2 antibodies 60 Figure 2.7. Regulation of TRPV2 trafficking by insulin-like growth factor-1 in CHO-K1 cells 61 vii Figure 2.8. Effect of IGF-1 on endogenous TRPV2 trafficking in F11 cells 63 Figure 3.1. NGF upregulates TRPV2 in models of developing neurons 95 Figure 3.2. NGF treatment results in sustained upregulation of TRPV2 expression in PC12 cells 96 Figure 3.3. Dominant negative TRPV2 co-assembles with WT TRPV2 98 Figure 3.4. Expression of DN TRPV2 reduces the Ca2+ response of F11 cells to 2-APB 99 Figure 3.5. TRPV2 overexpression enhances neurite outgrowth in F11 cells 100 Figure 3.6. TRPV2 activity enhances NGF-induced neurite outgrowth in PC12 cells 101 Figure 3.7. Silencing TRPV2 expression impairs NGF-induced neurite outgrowth 102 Figure 3.8. MAPK signaling mediates upregulation of TRPV2 103 Figure 3.9. NGF does not induce translocation of TRPV2 to the plasma membrane in PC12 cells 105 Figure 3.10. TRPV2 is phosphorylated by ERK 106 Figure 3.11. Mass spectrometry analysis of heterologously expressed TRPV2 to determine phosphorylation sites 107 Figure 3.12. Phosphorylation of TRPV2 by ERK enhances NGF-induced neurite outgrowth in PC12 cells 109 Figure 3.13. Model depicting the proposed mechanism by which NGF- activated MAPK signaling affects TRPV2 to enhance neurite outgrowth 111 viii Figure 4.1. Summary of findings 133 Figure 4.2. Rab GTPase cycle 134 Figure 4.3. Possible mechanism proposing how increased TRPV2 expression might affect longevity of NGF signals 135 Figure 4.4. Mechanism predicting how TRPV2 activity might increase neurite outgrowth 136 ix ACKNOWLEDGEMENTS I am especially grateful to my PhD advisor, Dr. Vera Moiseenkova-Bell. I approached Vera in the summer of 2010 as a first year student with very limited experience in the lab. I am lucky that she took a risk in allowing me to rotate in her lab and also in eventually accepting me as her first graduate student. I think in the end it worked out for both of us. I would also like to thank the members of the Moiseenkova-Bell lab: Kevin Huynh, who taught me all of the basic molecular biology techniques that I used to complete this dissertation; Teresa Cvetkov, who was always present as another mentor in my earlier days in the lab; Amrita Samanta and Xu Han, who both brought a great deal of energy during the latter portion of my time in the lab. I was very lucky to work with four very talented undergraduate students: Christian Marks, Monica Kane, Jennifer Pilat and Connor Dawedeit. In addition, I would like to thank Will Johnson. Will not only provided technical assistance but he also served as an objective critic, an ally, a colleague and a friend. He was certainly essential for taking my project to the next level. Thank you to my dissertation committee (Dr. Witold Surewicz, Dr. William Schilling, Dr. Sudha Chakrapani, Dr. David Van Wagoner and Dr. Xin Qi) for constantly challenging me, forcing me to stay focused and supporting me in my completion of these studies. Additional thanks go to Dr. Richard Zigmond, Alicia Lizowicz and Dr. Jana Kiselar. Thank you to my family for support throughout the past 6 years; to Kathleen – sometimes I feel like I could not have done this without you. Finally, thank you to all of the friends and colleagues who essential for my success during graduate school whom I did not mention here. x Understanding the Regulation of Endogenous TRPV2 by Growth Factors in Neuronal Cells Abstract By MATTHEW RYAN COHEN Transient receptor potential vanilloid 2 (TRPV2) is a non-selective Ca2+- permeable cation channel that belongs to the vanilloid subfamily of the TRP superfamily.
Recommended publications
  • Ankrd9 Is a Metabolically-Controlled Regulator of Impdh2 Abundance and Macro-Assembly

    Ankrd9 Is a Metabolically-Controlled Regulator of Impdh2 Abundance and Macro-Assembly

    ANKRD9 IS A METABOLICALLY-CONTROLLED REGULATOR OF IMPDH2 ABUNDANCE AND MACRO-ASSEMBLY by Dawn Hayward A dissertation submitted to The Johns Hopkins University in conformity with the requirements of the degree of Doctor of Philosophy Baltimore, Maryland April 2019 ABSTRACT Members of a large family of Ankyrin Repeat Domains proteins (ANKRD) regulate numerous cellular processes by binding and changing properties of specific protein targets. We show that interactions with a target protein and the functional outcomes can be markedly altered by cells’ metabolic state. ANKRD9 facilitates degradation of inosine monophosphate dehydrogenase 2 (IMPDH2), the rate-limiting enzyme in GTP biosynthesis. Under basal conditions ANKRD9 is largely segregated from the cytosolic IMPDH2 by binding to vesicles. Upon nutrient limitation, ANKRD9 loses association with vesicles and assembles with IMPDH2 into rod-like structures, in which IMPDH2 is stable. Inhibition of IMPDH2 with Ribavirin favors ANKRD9 binding to rods. The IMPDH2/ANKRD9 assembly is reversed by guanosine, which restores association of ANKRD9 with vesicles. The conserved Cys109Cys110 motif in ANKRD9 is required for the vesicles-to-rods transition as well as binding and regulation of IMPDH2. ANKRD9 knockdown increases IMPDH2 levels and prevents formation of IMPDH2 rods upon nutrient limitation. Thus, the status of guanosine pools affects the mode of ANKRD9 action towards IMPDH2. Advisor: Dr. Svetlana Lutsenko, Department of Physiology, Johns Hopkins University School of Medicine Second reader:
  • Repeat Proteins Challenge the Concept of Structural Domains

    Repeat Proteins Challenge the Concept of Structural Domains

    844 Biochemical Society Transactions (2015) Volume 43, part 5 Repeat proteins challenge the concept of structural domains Rocıo´ Espada*1, R. Gonzalo Parra*1, Manfred J. Sippl†, Thierry Mora‡, Aleksandra M. Walczak§ and Diego U. Ferreiro*2 *Protein Physiology Lab, Dep de Qu´ımica Biologica, ´ Facultad de Ciencias Exactas y Naturales, UBA-CONICET-IQUIBICEN, Buenos Aires, C1430EGA, Argentina †Center of Applied Molecular Engineering, Division of Bioinformatics, Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria ‡Laboratoire de physique statistique, CNRS, UPMC and Ecole normale superieure, ´ 24 rue Lhomond, 75005 Paris, France §Laboratoire de physique theorique, ´ CNRS, UPMC and Ecole normale superieure, ´ 24 rue Lhomond, 75005 Paris, France Abstract Structural domains are believed to be modules within proteins that can fold and function independently. Some proteins show tandem repetitions of apparent modular structure that do not fold independently, but rather co-operate in stabilizing structural forms that comprise several repeat-units. For many natural repeat-proteins, it has been shown that weak energetic links between repeats lead to the breakdown of co-operativity and the appearance of folding sub-domains within an apparently regular repeat array. The quasi-1D architecture of repeat-proteins is crucial in detailing how the local energetic balances can modulate the folding dynamics of these proteins, which can be related to the physiological behaviour of these ubiquitous biological systems. Introduction and between repeats, challenging the concept of structural It was early on noted that many natural proteins typically domain. collapse stretches of amino acid chains into compact units, defining structural domains [1]. These domains typically correlate with biological activities and many modern proteins can be described as composed by novel ‘domain arrange- Definition of the repeat-units ments’ [2].
  • A Structural Guide to Proteins of the NF-Kb Signaling Module

    A Structural Guide to Proteins of the NF-Kb Signaling Module

    Downloaded from http://cshperspectives.cshlp.org/ on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press A Structural Guide to Proteins of the NF-kB Signaling Module Tom Huxford1 and Gourisankar Ghosh2 1Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California 92182-1030 2Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0375 Correspondence: [email protected] The prosurvival transcription factor NF-kB specifically binds promoter DNA to activate target gene expression. NF-kB is regulated through interactions with IkB inhibitor proteins. Active proteolysis of these IkB proteins is, in turn, under the control of the IkB kinase complex (IKK). Together, these three molecules form the NF-kB signaling module. Studies aimed at charac- terizing the molecular mechanisms of NF-kB, IkB, and IKK in terms of their three-dimen- sional structures have lead to a greater understanding of this vital transcription factor system. F-kB is a master transcription factor that from the perspective of their three-dimensional Nresponds to diverse cell stimuli by activat- structures. ing the expression of stress response genes. Multiple signals, including cytokines, growth factors, engagement of the T-cell receptor, and NF-kB bacterial and viral products, induce NF-kB Introduction to NF-kB transcriptional activity (Hayden and Ghosh 2008). A point of convergence for the myriad NF-kB was discovered in the laboratory of of NF-kB inducing signals is the IkB kinase David Baltimore as a nuclear activity with bind- complex (IKK). Active IKK in turn controls ing specificity toward a ten-base-pair DNA transcription factor NF-kB by regulating pro- sequence 50-GGGACTTTCC-30 present within teolysis of the IkB inhibitor protein (Fig.
  • Supp. Table S2: Domains and Protein Families with a Putative Role in Host-Symbiont Interactions

    Supp. Table S2: Domains and Protein Families with a Putative Role in Host-Symbiont Interactions

    Supp. Table S2: Domains and protein families with a putative role in host-symbiont interactions. The domains and protein families listed here were included in the comparisons in Figure 5 and Supp. Figure S5, which show the percentage of the respective protein groups in the Riftia symbiont metagenome and in metagenomes of other symbiotic and free-living organisms. % bacterial, total number bacterial: Percentage and total number of bacterial species in which this domain is found in the SMART database (January 2019). Domain name Pfam/SMART % bacterial (total Literature/comment annotation number bacterial) Alpha-2- alpha-2- A2M: 42.05% (2057) A2Ms: protease inhibitors which are important for eukaryotic macroglobulin macroglobulin innate immunity, if present in prokaryotes apparently fulfill a family (A2M), similar role, e.g. protection against host proteases (1) including N- terminal MG1 domain ANAPC Anaphase- APC2: 0 Ubiquitin ligase, important for cell cycle control in eukaryotes (2) promoting complex Bacterial proteins might interact with ubiquitination pathways in subunits the host (3) Ankyrin Ankyrin repeats 10.88% (8348) Mediate protein-protein interactions without sequence specificity (4) Sponge symbiont ankyrin-repeat proteins inhibit amoebal phagocytosis (5) Present in sponge microbiome metatranscriptomes, putative role in symbiont-host interactions (6) Present in obligate intracellular amoeba symbiont Candidatus Amoebophilus asiaticus genome, probable function in interactions with the host (7) Armadillo Armadillo repeats 0.83% (67)
  • Cryo-EM Structure of the Polycystic Kidney Disease-Like Channel PKD2L1

    Cryo-EM Structure of the Polycystic Kidney Disease-Like Channel PKD2L1

    ARTICLE DOI: 10.1038/s41467-018-03606-0 OPEN Cryo-EM structure of the polycystic kidney disease-like channel PKD2L1 Qiang Su1,2,3, Feizhuo Hu1,3,4, Yuxia Liu4,5,6,7, Xiaofei Ge1,2, Changlin Mei8, Shengqiang Yu8, Aiwen Shen8, Qiang Zhou1,3,4,9, Chuangye Yan1,2,3,9, Jianlin Lei 1,2,3, Yanqing Zhang1,2,3,9, Xiaodong Liu2,4,5,6,7 & Tingliang Wang1,3,4,9 PKD2L1, also termed TRPP3 from the TRPP subfamily (polycystic TRP channels), is involved 1234567890():,; in the sour sensation and other pH-dependent processes. PKD2L1 is believed to be a non- selective cation channel that can be regulated by voltage, protons, and calcium. Despite its considerable importance, the molecular mechanisms underlying PKD2L1 regulations are largely unknown. Here, we determine the PKD2L1 atomic structure at 3.38 Å resolution by cryo-electron microscopy, whereby side chains of nearly all residues are assigned. Unlike its ortholog PKD2, the pore helix (PH) and transmembrane segment 6 (S6) of PKD2L1, which are involved in upper and lower-gate opening, adopt an open conformation. Structural comparisons of PKD2L1 with a PKD2-based homologous model indicate that the pore domain dilation is coupled to conformational changes of voltage-sensing domains (VSDs) via a series of π–π interactions, suggesting a potential PKD2L1 gating mechanism. 1 Ministry of Education Key Laboratory of Protein Science, Tsinghua University, Beijing 100084, China. 2 School of Life Sciences, Tsinghua University, Beijing 100084, China. 3 Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing 100084, China. 4 School of Medicine, Tsinghua University, Beijing 100084, China.
  • Macromolecular Assembly of Polycystin-2 Intracytosolic C-Terminal Domain

    Macromolecular Assembly of Polycystin-2 Intracytosolic C-Terminal Domain

    Macromolecular assembly of polycystin-2 intracytosolic C-terminal domain Frederico M. Ferreiraa,b,1, Leandro C. Oliveirac, Gregory G. Germinod, José N. Onuchicc,1, and Luiz F. Onuchica,1 aDivision of Nephrology, University of São Paulo School of Medicine, 01246-903, São Paulo, Brazil; bLaboratory of Immunology, Heart Institute, University of São Paulo School of Medicine, 05403-900, São Paulo, Brazil; cCenter for Theoretical Biological Physics, University of California at San Diego, La Jolla, CA 92093; dNational Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, MD 20892-2560 Contributed by José N. Onuchic, April 28, 2011 (sent for review March 20, 2011) Mutations in PKD2 are responsible for approximately 15% of the In spite of the aforementioned information and insights, the autosomal dominant polycystic kidney disease cases. This gene macromolecular assembly of PC2t homooligomer continued to encodes polycystin-2, a calcium-permeable cation channel whose be an open question. In the current work, we present the most C-terminal intracytosolic tail (PC2t) plays an important role in its comprehensive set of analyses yet performed and that show interaction with a number of different proteins. In the present PC2t forms a homotetrameric oligomer. We have proposed a study, we have comprehensively evaluated the macromolecular PC2 C-terminal domain delimitation and submitted it to a range assembly of PC2t homooligomer using a series of biophysical of biochemical and biophysical evaluations, including chemical and biochemical analyses. Our studies, based on a new delimitation cross-linking, dynamic light scattering (DLS), circular dichroism of PC2t, have revealed that it is capable of assembling as a homo- (CD) and small angle X-ray scattering (SAXS) analyses.
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant

    Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant

    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
  • Data-Driven Analysis of TRP Channels in Cancer

    Data-Driven Analysis of TRP Channels in Cancer

    CANCER GENOMICS & PROTEOMICS 13 : 83-90 (2016) Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical Significance YU RANG PARK 1* , JUNG NYEO CHUN 2* , INSUK SO 2, HWA JUNG KIM 3, SEUNGHEE BAEK 4, JU-HONG JEON 2 and SOO-YONG SHIN 1,5 1Office of Clinical Research Information, and Departments of 3Clinical Epidemiology and Biostatistics, and 5Biomedical Informatics, Asan Medical Center, Seoul, Republic of Korea; 2Department of Physiology and Biomedical Sciences, Institute of Human-Environment Interface Biology, Seoul National University College of Medicine, Seoul, Republic of Korea; 4Department of Preventive Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea Abstract. Background: Experimental evidence has intracellular Ca 2+ in response to various internal and external suggested that transient receptor potential (TRP) channels stimuli (1, 2). In human, the TRP channel superfamily play a crucial role in tumor biology. However, clinical consists of 27 isotypes that are classified into six subfamilies relevance and significance of TRP channels in cancer remain (3): canonical (TRPC), vanilloid (TRPV), melastatin (TRPM), largely unknown. Materials and Methods: We applied a data- polycystin (TRPP), mucolipin (TRPML), and ankyrin driven approach to dissect the expression landscape of 27 (TRPA). Emerging evidence has shown that the aberrant TRP channel genes in 14 types of human cancer using functions of TRP channels are closely associated with cancer International Cancer Genome Consortium data. Results: hallmarks, such as sustaining proliferative signaling, evading TRPM2 was found overexpressed in most tumors, whereas growth suppressors, resisting cell death, and activating TRPM3 was broadly down-regulated. TRPV4 and TRPA1 invasion and metastasis (4, 5).
  • WSB1: from Homeostasis to Hypoxia Moinul Haque1,2,3, Joseph Keith Kendal1,2,3, Ryan Matthew Macisaac1,2,3 and Douglas James Demetrick1,2,3,4*

    WSB1: from Homeostasis to Hypoxia Moinul Haque1,2,3, Joseph Keith Kendal1,2,3, Ryan Matthew Macisaac1,2,3 and Douglas James Demetrick1,2,3,4*

    Haque et al. Journal of Biomedical Science (2016) 23:61 DOI 10.1186/s12929-016-0270-3 REVIEW Open Access WSB1: from homeostasis to hypoxia Moinul Haque1,2,3, Joseph Keith Kendal1,2,3, Ryan Matthew MacIsaac1,2,3 and Douglas James Demetrick1,2,3,4* Abstract The wsb1 gene has been identified to be important in developmental biology and cancer. A complex transcriptional regulation of wsb1 yields at least three functional transcripts. The major expressed isoform, WSB1 protein, is a substrate recognition protein within an E3 ubiquitin ligase, with the capability to bind diverse targets and mediate ubiquitinylation and proteolytic degradation. Recent data suggests a new role for WSB1 as a component of a neuroprotective pathway which results in modification and aggregation of neurotoxic proteins such as LRRK2 in Parkinson’s Disease, via an unusual mode of protein ubiquitinylation. WSB1 is also involved in thyroid hormone homeostasis, immune regulation and cellular metabolism, particularly glucose metabolism and hypoxia. In hypoxia, wsb1 is a HIF-1 target, and is a regulator of the degradation of diverse proteins associated with the cellular response to hypoxia, including HIPK2, RhoGDI2 and VHL. Major roles are to both protect HIF-1 function through degradation of VHL, and decrease apoptosis through degradation of HIPK2. These activities suggest a role for wsb1 in cancer cell proliferation and metastasis. As well, recent work has identified a role for WSB1 in glucose metabolism, and perhaps in mediating the Warburg effect in cancer cells by maintaining the function of HIF1. Furthermore, studies of cancer specimens have identified dysregulation of wsb1 associated with several types of cancer, suggesting a biologically relevant role in cancer development and/or progression.
  • The Heteromeric PC-1/PC-2 Polycystin Complex Is Activated by the PC-1 N-Terminus

    The Heteromeric PC-1/PC-2 Polycystin Complex Is Activated by the PC-1 N-Terminus

    RESEARCH ARTICLE The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus Kotdaji Ha1, Mai Nobuhara1, Qinzhe Wang2, Rebecca V Walker3, Feng Qian3, Christoph Schartner1, Erhu Cao2, Markus Delling1* 1Department of Physiology, University of California, San Francisco, San Francisco, United States; 2Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, United States; 3Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, United States Abstract Mutations in the polycystin proteins, PC-1 and PC-2, result in autosomal dominant polycystic kidney disease (ADPKD) and ultimately renal failure. PC-1 and PC-2 enrich on primary cilia, where they are thought to form a heteromeric ion channel complex. However, a functional understanding of the putative PC-1/PC-2 polycystin complex is lacking due to technical hurdles in reliably measuring its activity. Here we successfully reconstitute the PC-1/PC-2 complex in the plasma membrane of mammalian cells and show that it functions as an outwardly rectifying channel. Using both reconstituted and ciliary polycystin channels, we further show that a soluble fragment generated from the N-terminal extracellular domain of PC-1 functions as an intrinsic agonist that is necessary and sufficient for channel activation. We thus propose that autoproteolytic cleavage of the N-terminus of PC-1, a hotspot for ADPKD mutations, produces a soluble ligand in vivo. These findings establish a mechanistic framework for understanding the role of PC-1/PC-2 heteromers in ADPKD and suggest new therapeutic strategies that would expand upon the limited symptomatic treatments currently available for this progressive, terminal disease.
  • Opening TRPP2 (PKD2L1) Requires the Transfer of Gating Charges

    Opening TRPP2 (PKD2L1) Requires the Transfer of Gating Charges

    Opening TRPP2 (PKD2L1) requires the transfer of gating charges Leo C. T. Nga, Thuy N. Viena, Vladimir Yarov-Yarovoyb, and Paul G. DeCaena,1 aDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611; and bDepartment of Physiology and Membrane Biology, University of California, Davis, CA 95616 Edited by Richard W. Aldrich, The University of Texas at Austin, Austin, TX, and approved June 19, 2019 (received for review February 18, 2019) The opening of voltage-gated ion channels is initiated by transfer their ligands (exogenous or endogenous) is sufficient to initiate of gating charges that sense the electric field across the mem- channel opening. Although TRP channels share a similar to- brane. Although transient receptor potential ion channels (TRP) pology with most VGICs, few are intrinsically voltage gated, and are members of this family, their opening is not intrinsically linked most do not have gating charges within their VSD-like domains to membrane potential, and they are generally not considered (16). Current conducted by TRP family members is often rectifying, voltage gated. Here we demonstrate that TRPP2, a member of the but this form of voltage dependence is usually attributed to divalent polycystin subfamily of TRP channels encoded by the PKD2L1 block or other conditional effects (17, 18). There are 3 members of gene, is an exception to this rule. TRPP2 borrows a biophysical riff the polycystin subclass: TRPP1 (PKD2 or polycystin-2), TRPP2 from canonical voltage-gated ion channels, using 2 gating charges (PKD2-L1 or polycystin-L), and TRPP3 (PKD2-L2). TRPP1 is the found in its fourth transmembrane segment (S4) to control its con- founding member of this family, and variants in the PKD2 gene ductive state.
  • Drug Discovery for Polycystic Kidney Disease

    Drug Discovery for Polycystic Kidney Disease

    Acta Pharmacologica Sinica (2011) 32: 805–816 npg © 2011 CPS and SIMM All rights reserved 1671-4083/11 $32.00 www.nature.com/aps Review Drug discovery for polycystic kidney disease Ying SUN, Hong ZHOU, Bao-xue YANG* Department of Pharmacology, School of Basic Medical Sciences, Peking University, and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing 100191, China In polycystic kidney disease (PKD), a most common human genetic diseases, fluid-filled cysts displace normal renal tubules and cause end-stage renal failure. PKD is a serious and costly disorder. There is no available therapy that prevents or slows down the cystogen- esis and cyst expansion in PKD. Numerous efforts have been made to find drug targets and the candidate drugs to treat PKD. Recent studies have defined the mechanisms underlying PKD and new therapies directed toward them. In this review article, we summarize the pathogenesis of PKD, possible drug targets, available PKD models for screening and evaluating new drugs as well as candidate drugs that are being developed. Keywords: polycystic kidney disease; drug discovery; kidney; candidate drugs; animal model Acta Pharmacologica Sinica (2011) 32: 805–816; doi: 10.1038/aps.2011.29 Introduction the segments of the nephron. Autosomal recessive polycystic Polycystic kidney disease (PKD), an inherited human renal kidney disease (ARPKD) results primarily from the mutations disease, is characterized by massive enlargement of fluid- in a single gene, Pkhd1[14]. Its frequency is estimated to be filled renal tubular and/or collecting duct cysts[1]. Progres- one per 20000 individuals. The PKHD1 protein, fibrocystin, sively enlarging cysts compromise normal renal parenchyma, has been found to be localized to primary cilia and the basal often leading to renal failure.